Algorithmic surveillance of ICU patients with acute respiratory distress syndrome (ASIC): protocol for a multicentre stepped-wedge cluster randomised quality improvement strategy
Standard
Algorithmic surveillance of ICU patients with acute respiratory distress syndrome (ASIC): protocol for a multicentre stepped-wedge cluster randomised quality improvement strategy. / Marx, Gernot; Bickenbach, Johannes; Fritsch, Sebastian Johannes; Kunze, Julian Benedict; Maassen, Oliver; Deffge, Saskia; Kistermann, Jennifer; Haferkamp, Silke; Lutz, Irina; Voellm, Nora Kristiana; Lowitsch, Volker; Polzin, Richard; Sharafutdinov, Konstantin; Mayer, Hannah; Kuepfer, Lars; Burghaus, Rolf; Schmitt, Walter; Lippert, Joerg; Riedel, Morris; Barakat, Chadi; Stollenwerk, André; Fonck, Simon; Putensen, Christian; Zenker, Sven; Erdfelder, Felix; Grigutsch, Daniel; Kram, Rainer; Beyer, Susanne; Kampe, Knut; Gewehr, Jan Erik; Salman, Friederike; Juers, Patrick; Kluge, Stefan; Tiller, Daniel; Wisotzki, Emilia; Gross, Sebastian; Homeister, Lorenz; Bloos, Frank; Scherag, André; Ammon, Danny; Mueller, Susanne; Palm, Julia; Simon, Philipp; Jahn, Nora; Loeffler, Markus; Wendt, Thomas; Schuerholz, Tobias; Groeber, Petra; Schuppert, Andreas.
in: BMJ OPEN, Jahrgang 11, Nr. 4, e045589, 08.04.2021.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Algorithmic surveillance of ICU patients with acute respiratory distress syndrome (ASIC): protocol for a multicentre stepped-wedge cluster randomised quality improvement strategy
AU - Marx, Gernot
AU - Bickenbach, Johannes
AU - Fritsch, Sebastian Johannes
AU - Kunze, Julian Benedict
AU - Maassen, Oliver
AU - Deffge, Saskia
AU - Kistermann, Jennifer
AU - Haferkamp, Silke
AU - Lutz, Irina
AU - Voellm, Nora Kristiana
AU - Lowitsch, Volker
AU - Polzin, Richard
AU - Sharafutdinov, Konstantin
AU - Mayer, Hannah
AU - Kuepfer, Lars
AU - Burghaus, Rolf
AU - Schmitt, Walter
AU - Lippert, Joerg
AU - Riedel, Morris
AU - Barakat, Chadi
AU - Stollenwerk, André
AU - Fonck, Simon
AU - Putensen, Christian
AU - Zenker, Sven
AU - Erdfelder, Felix
AU - Grigutsch, Daniel
AU - Kram, Rainer
AU - Beyer, Susanne
AU - Kampe, Knut
AU - Gewehr, Jan Erik
AU - Salman, Friederike
AU - Juers, Patrick
AU - Kluge, Stefan
AU - Tiller, Daniel
AU - Wisotzki, Emilia
AU - Gross, Sebastian
AU - Homeister, Lorenz
AU - Bloos, Frank
AU - Scherag, André
AU - Ammon, Danny
AU - Mueller, Susanne
AU - Palm, Julia
AU - Simon, Philipp
AU - Jahn, Nora
AU - Loeffler, Markus
AU - Wendt, Thomas
AU - Schuerholz, Tobias
AU - Groeber, Petra
AU - Schuppert, Andreas
PY - 2021/4/8
Y1 - 2021/4/8
N2 - INTRODUCTION: The acute respiratory distress syndrome (ARDS) is a highly relevant entity in critical care with mortality rates of 40%. Despite extensive scientific efforts, outcome-relevant therapeutic measures are still insufficiently practised at the bedside. Thus, there is a clear need to adhere to early diagnosis and sufficient therapy in ARDS, assuring lower mortality and multiple organ failure.METHODS AND ANALYSIS: In this quality improvement strategy (QIS), a decision support system as a mobile application (ASIC app), which uses available clinical real-time data, is implemented to support physicians in timely diagnosis and improvement of adherence to established guidelines in the treatment of ARDS. ASIC is conducted on 31 intensive care units (ICUs) at 8 German university hospitals. It is designed as a multicentre stepped-wedge cluster randomised QIS. ICUs are combined into 12 clusters which are randomised in 12 steps. After preparation (18 months) and a control phase of 8 months for all clusters, the first cluster enters a roll-in phase (3 months) that is followed by the actual QIS phase. The remaining clusters follow in month wise steps. The coprimary key performance indicators (KPIs) consist of the ARDS diagnostic rate and guideline adherence regarding lung-protective ventilation. Secondary KPIs include the prevalence of organ dysfunction within 28 days after diagnosis or ICU discharge, the treatment duration on ICU and the hospital mortality. Furthermore, the user acceptance and usability of new technologies in medicine are examined. To show improvements in healthcare of patients with ARDS, differences in primary and secondary KPIs between control phase and QIS will be tested.ETHICS AND DISSEMINATION: Ethical approval was obtained from the independent Ethics Committee (EC) at the RWTH Aachen Faculty of Medicine (local EC reference number: EK 102/19) and the respective data protection officer in March 2019. The results of the ASIC QIS will be presented at conferences and published in peer-reviewed journals.TRIAL REGISTRATION NUMBER: DRKS00014330.
AB - INTRODUCTION: The acute respiratory distress syndrome (ARDS) is a highly relevant entity in critical care with mortality rates of 40%. Despite extensive scientific efforts, outcome-relevant therapeutic measures are still insufficiently practised at the bedside. Thus, there is a clear need to adhere to early diagnosis and sufficient therapy in ARDS, assuring lower mortality and multiple organ failure.METHODS AND ANALYSIS: In this quality improvement strategy (QIS), a decision support system as a mobile application (ASIC app), which uses available clinical real-time data, is implemented to support physicians in timely diagnosis and improvement of adherence to established guidelines in the treatment of ARDS. ASIC is conducted on 31 intensive care units (ICUs) at 8 German university hospitals. It is designed as a multicentre stepped-wedge cluster randomised QIS. ICUs are combined into 12 clusters which are randomised in 12 steps. After preparation (18 months) and a control phase of 8 months for all clusters, the first cluster enters a roll-in phase (3 months) that is followed by the actual QIS phase. The remaining clusters follow in month wise steps. The coprimary key performance indicators (KPIs) consist of the ARDS diagnostic rate and guideline adherence regarding lung-protective ventilation. Secondary KPIs include the prevalence of organ dysfunction within 28 days after diagnosis or ICU discharge, the treatment duration on ICU and the hospital mortality. Furthermore, the user acceptance and usability of new technologies in medicine are examined. To show improvements in healthcare of patients with ARDS, differences in primary and secondary KPIs between control phase and QIS will be tested.ETHICS AND DISSEMINATION: Ethical approval was obtained from the independent Ethics Committee (EC) at the RWTH Aachen Faculty of Medicine (local EC reference number: EK 102/19) and the respective data protection officer in March 2019. The results of the ASIC QIS will be presented at conferences and published in peer-reviewed journals.TRIAL REGISTRATION NUMBER: DRKS00014330.
U2 - 10.1136/bmjopen-2020-045589
DO - 10.1136/bmjopen-2020-045589
M3 - SCORING: Journal article
C2 - 34550901
VL - 11
JO - BMJ OPEN
JF - BMJ OPEN
SN - 2044-6055
IS - 4
M1 - e045589
ER -